NCT00997945View on ClinicalTrials.gov

10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

April 30, 2011

Conditions

Advanced Solid Malignancies

Interventions

DRUG

ZD4054 (Zibotentan)

10 mg ZD4054 (Zibotentan) once daily on Day1, Day4 to Day15

Trial Locations (1)

Unknown

Research Site, Shanghai

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY